Statin Therapy In Patients With Vasospastic Angina — STAVA

Angina Pectoris, Variant Clinical Trial

Official title:
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of Statin Therapy In Patients With Vasospastic Angina

Status Withdrawn

Clinical Trial Summary

The purpose of this study is to evaluate whether statin is effective in the treatment of vasospastic angina.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02790528
Study type	Interventional
Source	Asan Medical Center
Contact
Status	Withdrawn
Phase	Phase 4
Start date	July 2017
Completion date	December 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02845531` - Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death	Phase 4
Active, not recruiting	`NCT01318629` - Angina in Non Coronary Artery Disease	N/A
Recruiting	`NCT05618132` - ReACHallenge Trial: Acetylcholine Rechallenge After Pretreatment With Vasoactive Drugs	N/A
Recruiting	`NCT00620204` - Efficacy Study of Atorvastatin to Treat Variant Angina	Phase 4
Active, not recruiting	`NCT03477890` - Coronary Microvascular Function and CT Coronary Angiography (CorCTCA)	N/A
Withdrawn	`NCT02932553` - BVS Implantation in Patients With Variant Angina and MODerate Coronary Artery Disease	Phase 4